- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 23, 2019
Company News
Biogen prioritizing new areas as it awaits SMA landscape changes
BioCentury | Oct 26, 2018
Clinical News
Biogen, UCB report Phase IIb miss for lupus candidate dapirolizumab
BioCentury | Oct 23, 2018
Company News
Biogen halts vixotrigine development in painful lumbosacral radiculopathy
BioCentury | May 5, 2018
Product Development
Rebuilding Biogen’s brain
What Biogen is building in neurology
Items per page:
1 - 7 of 7